Procter & Gamble Hygiene and Health Care Ltd.
8,902.00+16.0 (+0.18%)
3 Jul, 3:30 PM
Analyst Ratings and Targets
Procter & Gamble Hygiene and Health Care Ltd. analyst ratings, buy/sell/hold recommendations and 12-month price targets from leading brokerages.
Analyst Ratings
Total recommendations
4
Analysts with Strong Buy
1
Analysts with buy
2
75.0%
75% of analysts have buy or strong buy on this stock implying positive street outlook.
Analysts with Strong Buy
1
Analysts with buy
2
Analysts with hold
1
Analysts with Sell
0
Analysts with Strong Sell
0
Target Price
Current market price
₹ 8,902.00
Median target price
₹ 11,084.00 (24.51%)
Highest target price
₹ 14,300.00 (60.64%)
Average target price
₹ 10,817.00 (21.51%)
Lowest target price
₹ 6,800.00 (-23.61%)
Financial Estimates
Procter & Gamble Hygiene and Health Care Ltd. analyst consensus estimates for revenue, EBITDA, PAT and EPS (consolidated) for the next 2 financial years on a rolling basis.
EPS for FY Jun 25: ₹ 255.28 /share
Estimated EPS for FY Jun 26
Median
₹ 262.80(2.94 %)
High
₹ 263.50(3.22 %)
Mean
₹ 249.87(-2.12 %)
Low
₹ 223.30(-12.53 %)
Estimated EPS for FY Jun 27
Median
₹ 283.10(5.31 %)
High
₹ 291.30(6.82 %)
Mean
₹ 266.43(2.16 %)
Low
₹ 224.90(-6.14 %)
BPS for FY Jun 25: -
Estimated BPS for FY Jun 26
Median
₹ 261.70
High
₹ 349.70
Mean
₹ 276.30
Low
₹ 232.10
Estimated BPS for FY Jun 27
Median
₹ 304.40
High
₹ 477.40
Mean
₹ 342.18
Low
₹ 282.50
Sales for FY Jun 25: ₹ 4.31 k Cr
Estimated Sales for FY Jun 26
Median
₹ 4.36 k Cr(1.23 %)
High
₹ 4.44 k Cr(2.95 %)
Mean
₹ 4.36 k Cr(1.23 %)
Low
₹ 4.29 k Cr(-0.49 %)
Estimated Sales for FY Jun 27
Median
₹ 4.72 k Cr(4.68 %)
High
₹ 4.86 k Cr(6.12 %)
Mean
₹ 4.72 k Cr(4.68 %)
Low
₹ 4.59 k Cr(3.22 %)
Estimates Revision
How Procter & Gamble Hygiene and Health Care Ltd. analyst consensus for revenue and earnings has been revised over the last 12 months.
EPS revisions in the last 12 months
EPS estimate for FY end:
Jun 2026
Frequently Asked Questions
What is the analyst consensus recommendation for Procter & Gamble Hygiene and Health Care Ltd.?
The analyst consensus for Procter & Gamble Hygiene and Health Care Ltd. is Buy. Out of 4 analysts covering the stock, 3 have a Buy or Strong Buy rating (75%), 1 have a Hold and 0 have a Sell or Strong Sell rating.
What is the target price for Procter & Gamble Hygiene and Health Care Ltd.?
The median analyst target price for Procter & Gamble Hygiene and Health Care Ltd. is ₹ 11,084.00, with a high target of ₹ 14,300.00 and a low target of ₹ 6,800.00. The mean (average) target is ₹ 10,817.00.
How many analysts cover Procter & Gamble Hygiene and Health Care Ltd.?
4 analysts actively cover Procter & Gamble Hygiene and Health Care Ltd.: 1 Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell.
What is the upside or downside potential for Procter & Gamble Hygiene and Health Care Ltd. from the current price?
Based on the current market price of ₹ 8,902.00 and the median analyst target of ₹ 11,084.00, there is a 24.5% upside potential for Procter & Gamble Hygiene and Health Care Ltd. according to analyst consensus.
What is the revenue estimate for Procter & Gamble Hygiene and Health Care Ltd. for the next financial year?
Analyst consensus estimates Procter & Gamble Hygiene and Health Care Ltd.'s revenue for FY 2026 at ₹ 4.36 k Cr (+1.2% growth), with analyst estimates ranging from ₹ 4.29 k Cr (low) to ₹ 4.44 k Cr (high). Full revenue and earnings estimates are in the Financial Estimates section.
What is the EPS estimate for Procter & Gamble Hygiene and Health Care Ltd.?
The current trailing twelve month EPS of Procter & Gamble Hygiene and Health Care Ltd. is 263.86. Analyst consensus estimates EPS for FY 2026 at ₹ 262.80 per share (+2.9% growth). Forward EPS estimates are in the Financial Estimates section.
What is the BPS estimate for Procter & Gamble Hygiene and Health Care Ltd.?
Analyst consensus estimates the Book Value Per Share (BPS) of Procter & Gamble Hygiene and Health Care Ltd. for FY 2026 at ₹ 261.70 per share. BPS reflects the net asset value attributable to each share and is used to assess the stock's price-to-book valuation. Forward BPS estimates are in the Financial Estimates section.
Are analysts bullish or bearish on Procter & Gamble Hygiene and Health Care Ltd.?
Analyst sentiment on Procter & Gamble Hygiene and Health Care Ltd. leans buy: 75% of analysts have a Buy or Strong Buy rating. The consensus outlook is updated as brokerages revise their ratings — see the Estimates Revision section for how views have shifted.
Has the analyst consensus for Procter & Gamble Hygiene and Health Care Ltd. been revised recently?
Estimate revision history for Procter & Gamble Hygiene and Health Care Ltd. is available in the Estimates Revision section of the Forecast tab, showing how analyst consensus for revenue and earnings has changed over the past 12 months.
What is the current PE ratio of Procter & Gamble Hygiene and Health Care Ltd. compared to the target implied PE?
The current trailing PE of Procter & Gamble Hygiene and Health Care Ltd. is 33.64. Based on the median analyst target price of ₹ 11,084.00 and TTM EPS of 263.86, the target-implied forward PE is approximately 42x.